Danny.
You can not be serious.This is the best biotech deal completed for the last 10 years .Not only the potential deal is us $335 million (approx$370 million aussie).The royalty stream at 20% is seriously big .Asuming axiron sell product for $500 million per year the royalty stream for acr is 100 million per year not a bad annuity i would have to say.Lets get the poorly informed sellers from bailleaus out the way and off to the races we go.
Add to My Watchlist
What is My Watchlist?
